These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28272772)

  • 1. TUSC3: a novel tumour suppressor gene and its functional implications.
    Yu X; Zhai C; Fan Y; Zhang J; Liang N; Liu F; Cao L; Wang J; Du J
    J Cell Mol Med; 2017 Sep; 21(9):1711-1718. PubMed ID: 28272772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells.
    Kratochvílová K; Horak P; Ešner M; Souček K; Pils D; Anees M; Tomasich E; Dráfi F; Jurtíková V; Hampl A; Krainer M; Vaňhara P
    Int J Cancer; 2015 Sep; 137(6):1330-40. PubMed ID: 25735931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of substrate specificity of human oligosaccharyl transferase subunit N33/Tusc3 and its role in regulating protein N-glycosylation.
    Mohorko E; Owen RL; Malojčić G; Brozzo MS; Aebi M; Glockshuber R
    Structure; 2014 Apr; 22(4):590-601. PubMed ID: 24685145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancer cells.
    Vaňhara P; Horak P; Pils D; Anees M; Petz M; Gregor W; Zeillinger R; Krainer M
    Int J Oncol; 2013 Apr; 42(4):1383-9. PubMed ID: 23404293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TUSC3: functional duality of a cancer gene.
    Vašíčková K; Horak P; Vaňhara P
    Cell Mol Life Sci; 2018 Mar; 75(5):849-857. PubMed ID: 28929175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous deletion in TUSC3 causing syndromic intellectual disability: a new patient.
    Loddo S; Parisi V; Doccini V; Filippi T; Bernardini L; Brovedani P; Ricci F; Novelli A; Battaglia A
    Am J Med Genet A; 2013 Aug; 161A(8):2084-7. PubMed ID: 23825019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.
    Horak P; Tomasich E; Vaňhara P; Kratochvílová K; Anees M; Marhold M; Lemberger CE; Gerschpacher M; Horvat R; Sibilia M; Pils D; Krainer M
    Sci Rep; 2014 Jan; 4():3739. PubMed ID: 24435307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A defect in the TUSC3 gene is associated with autosomal recessive mental retardation.
    Garshasbi M; Hadavi V; Habibi H; Kahrizi K; Kariminejad R; Behjati F; Tzschach A; Najmabadi H; Ropers HH; Kuss AW
    Am J Hum Genet; 2008 May; 82(5):1158-64. PubMed ID: 18452889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
    Pils D; Horak P; Vanhara P; Anees M; Petz M; Alfanz A; Gugerell A; Wittinger M; Gleiss A; Auner V; Tong D; Zeillinger R; Braicu EI; Sehouli J; Krainer M
    Cancer; 2013 Mar; 119(5):946-54. PubMed ID: 23096450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TUSC3 suppresses glioblastoma development by inhibiting Akt signaling.
    Jiang Z; Guo M; Zhang X; Yao L; Shen J; Ma G; Liu L; Zhao L; Xie C; Liang H; Wang H; Zhu M; Hu L; Song Y; Shen H; Lin Z
    Tumour Biol; 2016 Sep; 37(9):12039-12047. PubMed ID: 27177902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation.
    Molinari F; Foulquier F; Tarpey PS; Morelle W; Boissel S; Teague J; Edkins S; Futreal PA; Stratton MR; Turner G; Matthijs G; Gecz J; Munnich A; Colleaux L
    Am J Hum Genet; 2008 May; 82(5):1150-7. PubMed ID: 18455129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor candidate 3: A novel grading tool and predictor of clinical malignancy in human gliomas.
    Yuan J; Yu X; Wang A; Li Y; Liu F; Wang Y; Sun S; Bing X; Liu Y; Du J
    Oncol Lett; 2018 Apr; 15(4):5655-5661. PubMed ID: 29556302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer.
    Burgermeister E; Höde P; Betge J; Gutting T; Merkel A; Wu W; Tänzer M; Mossner M; Nowak D; Magdeburg J; Rückert F; Sticht C; Breitkopf-Heinlein K; Schulte N; Härtel N; Belle S; Post S; Gaiser T; Heppner BI; Behrens HM; Röcken C; Ebert MPA
    Oncotarget; 2017 Oct; 8(49):84714-84728. PubMed ID: 29156678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development.
    Zhou H; Clapham DE
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15750-5. PubMed ID: 19717468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease.
    Ding H; Li Y; Fang M; Chen J; Liu L; Lu Z; Hou J; Luo M
    J Allergy Clin Immunol; 2023 Jun; 151(6):1622-1633.e10. PubMed ID: 37086924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of TUSC3 gene polymorphisms with non-syndromic mental retardation based on nuclear families in the Qinba mountain area of China.
    Zhang MJ; Xing LX; Cui M; Yang X; Shi JG; Li J; Zhang KJ; Zheng ZJ; Zhang FC; Li JL; Gao XC
    Genet Mol Res; 2015 May; 14(2):5022-30. PubMed ID: 25966277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium transporter 1 (MAGT1) deficiency causes selective defects in
    Matsuda-Lennikov M; Biancalana M; Zou J; Ravell JC; Zheng L; Kanellopoulou C; Jiang P; Notarangelo G; Jing H; Masutani E; Oler AJ; Olano LR; Schulz BL; Lenardo MJ
    J Biol Chem; 2019 Sep; 294(37):13638-13656. PubMed ID: 31337704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor candidate TUSC3 expression during rat testis maturation.
    Khalid AM; Asano A; Hosaka YZ; Takeuchi T; Yamano Y
    Biosci Biotechnol Biochem; 2013; 77(10):2019-24. PubMed ID: 24096664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor candidate 3 as a novel predictor for lymph node metastasis in lung cancer patients.
    Yu X; Zhang K; Liu F; Zhang J; Zhai C; Cao L; Song X; Wang Y; Li B; Sun H; Du J
    Oncol Lett; 2016 Dec; 12(6):5099-5105. PubMed ID: 28105217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous Truncating Intragenic Duplication in TUSC3 Responsible for Rare Autosomal Recessive Nonsyndromic Intellectual Disability with No Clinical or Biochemical Metabolic Markers.
    El Chehadeh S; Bonnet C; Callier P; Béri M; Dupré T; Payet M; Ragon C; Mosca-Boidron AL; Marle N; Mugneret F; Masurel-Paulet A; Thevenon J; Seta N; Duplomb L; Jonveaux P; Faivre L; Thauvin-Robinet C
    JIMD Rep; 2015; 20():45-55. PubMed ID: 25626710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.